Literature DB >> 12063238

Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.

Diego J Covarrubias1, Patrick H Luetmer, Norbert G Campeau.   

Abstract

BACKGROUND AND
PURPOSE: The recently described posterior reversible encephalopathy syndrome (PRES) classically consists of reversible vasogenic edema in the posterior circulation territories, although conversion to irreversible cytotoxic edema has been described. We hypothesized that the extent of edema has prognostic implications and that diffusion-weighted MR imaging (DWI) can help predict the progression to infarction.
METHODS: Twenty-two patients with PRES and 18 control subjects were examined with isotropic DWI. Nineteen regions of interest (ROIs) were systematically placed, and apparent diffusion coefficients (ADCs) were computed and correlated with T2 and DWI signal intensity in each ROI.
RESULTS: T2 signal abnormalities were always present in territories of the posterior circulation. Anterior circulation structures were involved in 91% of patients. ADC values in areas of abnormal T2 signal were high. More extensive T2 signal abnormalities were seen in patients with a poor outcome than in patients who recovered. In six patients (27%), areas of high DWI signal intensity were seen with ADC values that were paradoxically normal, which we called pseudonormalized. Abnormal T2 signal intensity and high ADC values surrounded these areas. Follow-up images in two patients showed progression to infarction in pseudonormalized regions.
CONCLUSION: Vasogenic edema in PRES involves predominantly the posterior circulation territories, but anterior circulation structures are also frequently involved. The extent of combined T2 and DWI signal abnormalities correlate with patient outcome. High DWI signal intensity and pseudonormalized ADC values are associated with cerebral infarction and may represent the earliest sign of nonreversibility as severe vasogenic edema progresses to cytotoxic edema.

Entities:  

Mesh:

Year:  2002        PMID: 12063238      PMCID: PMC7976914     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  34 in total

1.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

2.  The reversible posterior cerebral edema syndrome.

Authors:  W P Dillon; H Rowley
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

3.  Cerebral circulation in acute arterial hypertension--protective effects of sympathetic nervous activity.

Authors:  M Beausang-Linder; A Bill
Journal:  Acta Physiol Scand       Date:  1981-02

4.  Brain in eclampsia: MR imaging with clinical correlation.

Authors:  T G Sanders; D A Clayman; L Sanchez-Ramos; F S Vines; L Russo
Journal:  Radiology       Date:  1991-08       Impact factor: 11.105

5.  Reversible tacrolimus-induced neurotoxicity isolated to the brain stem.

Authors:  P J Oliverio; L Restrepo; S A Mitchell; C S Tornatore; S R Frankel
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

6.  Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity.

Authors:  S C Coley; D A Porter; F Calamante; W K Chong; A Connelly
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

7.  Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases.

Authors:  R B Schwartz; S M Bravo; R A Klufas; L Hsu; P D Barnes; C D Robson; J H Antin
Journal:  AJR Am J Roentgenol       Date:  1995-09       Impact factor: 3.959

8.  MR imaging of reversible cyclosporin A-induced neurotoxicity.

Authors:  C L Truwit; C P Denaro; J R Lake; T DeMarco
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jul-Aug       Impact factor: 3.825

9.  Evidence that disruption of the blood-brain barrier precedes reduction in cerebral blood flow in hypertensive encephalopathy.

Authors:  K Tamaki; S Sadoshima; G L Baumbach; C Iadecola; D J Reis; D D Heistad
Journal:  Hypertension       Date:  1984 Mar-Apr       Impact factor: 10.190

10.  Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis.

Authors:  R B Schwartz; R V Mulkern; H Gudbjartsson; F Jolesz
Journal:  AJNR Am J Neuroradiol       Date:  1998-05       Impact factor: 3.825

View more
  162 in total

1.  Clinical and radiological features of brainstem variant of hypertensive encephalopathy.

Authors:  Ioannis Karakis; James A Macdonald; Maria Stefanidou; Carlos S Kase
Journal:  J Vasc Interv Neurol       Date:  2009-04

2.  Analysis of cyclosporin A-induced reversible cortical blindness by diffusion-weighted magnetic resonance imaging techniques.

Authors:  Shin-ichi Manabe; Satoshi Kashii; Yukio Miki; Yoshihito Honda
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

3.  A case of reversible posterior leukoencephalopathy syndrome in a patient on peritoneal dialysis.

Authors:  Mineaki Kitamura; Akira Furusu; Megumi Hirose; Tomoya Nishino; Yoko Obata; Tadashi Uramatsu; Shigeru Kohno
Journal:  Clin Exp Nephrol       Date:  2010-11-12       Impact factor: 2.801

4.  Posterior reversible encephalopathy syndrome coexists with acute cerebral infarction: challenges of blood pressure management.

Authors:  Luji Liu; Lihong Zhang
Journal:  Quant Imaging Med Surg       Date:  2020-12

5.  Posterior reversible encephalopathy syndrome in infection, sepsis, and shock.

Authors:  W S Bartynski; J F Boardman; Z R Zeigler; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

6.  Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

7.  Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?

Authors:  Christina Mueller-Mang; Thomas Mang; Agnes Pirker; Katharina Klein; Christine Prchla; Daniela Prayer
Journal:  Neuroradiology       Date:  2009-02-21       Impact factor: 2.804

8.  Contrast staining on CT after DSA in ischemic stroke patients progresses to infarction and rarely hemorrhages.

Authors:  Matthew R Amans; Daniel L Cooke; Maya Vella; Christopher F Dowd; Van V Halbach; Randall T Higashida; Steven W Hetts
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

9.  Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns.

Authors:  O Kastrup; M Schlamann; C Moenninghoff; M Forsting; S Goericke
Journal:  Clin Neuroradiol       Date:  2014-02-20       Impact factor: 3.649

10.  The role of tumor lysis in reversible posterior leukoencephalopathy syndrome.

Authors:  Emiko Kaito; Satoshi Terae; Ryoji Kobayashi; Kohsuke Kudo; Khin Khin Tha; Kazuo Miyasaka
Journal:  Pediatr Radiol       Date:  2005-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.